Selected outcome
before April 2027
73%
before April 2027 · 73%
Stored quote · checking the venue
- Scheduled end
- Nov 1, 2026 ET
- Resolution source
- Food and Drug Administration (opens in a new tab)
Price
Loading price history.
Markets
- before December
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?
32%
Open · ~$0 24h · ~$628 vol
Bid 28¢ · Ask 36¢
- before November
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?
4%
Open · ~$0 24h · ~$169 vol
Bid 2¢ · Ask 6¢
- before April 2027
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?
73%
Open · ~$0 24h · ~$1,772 vol
Bid 69¢ · Ask 76¢
- before 2027
When will Beam Therapeutics Inc. submit a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA?
51%
Open · ~$0 24h · ~$228 vol
Bid 50¢ · Ask 52¢
Event statistics
How this resolves
- Scheduled end
- Nov 1, 2026 ET
- Resolution source
- Trading
- Closed
- In review
- Resolved
Rules text
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.